Standard & Poor's
http://www2.standardandpoors.comStandard & Poor’s, a division of McGraw-Hill (NYSE: MHP), produces financial research and analysis on stocks and bonds. It provides credit ratings on public and private corporations and is designated as a Nationally Recognized Statistical Rating Organization (NRSRO) by the SEC. The firm’s long-term credit ratings range from “AAA” to “D” and its short-term credit ratings range from “A-1” to “D”. Standard & Poor’s also publishes indexes including the S&P 500.
-
S&P 500 dips after choppy session; chipmakers drag Nasdaq
-
S&P ekes out record on healthcare gains, tax plan hopes
-
Abbott Laboratories (ABT) Credit Rating Cut to 'BBB' from 'A+' at S&P Following St. Jude Closing
-
IDEXX Labs (IDXX) to Join S&P 500; Chemours (CC) to Join S&P MidCap 400; Shake Shack (SHAK) to Join S&P SmallCap 600
-
S&P Affirms Negative Outlook on Abbott (ABT) Amid Move to Acquire St. Jude Medical (STJ)
-
Abbott's (ABT) Ratings Placed on CreditWatch Negative by S&P Amid Alere (ALR) Deal
-
Evercore ISI Starts Abbott Labs (ABT) at Buy
-
Market Wrap: CPI Outpaces in Sept.; Regulus Ramps on RG-101 Data; AT&T Trims Outlook
-
Market Wrap: Time Warner Refuses Fox Bid; BofA Q2 Hit on Charge; Boeing Gets Jumbo Deal
-
Market Wrap: Citi Trounces Q2 Expectations; Merger Monday; Drug Stocks Active on Results
-
Pre-Open Stock Movers 4/16: (ZLCS) (SODA) (YHOO) Higher; (ASML) (CSX) (TWTR) Lower (more...)
-
Market Wrap: Icahn Back on the Hunt; Netflix Ramps on Profits; Mortgage Apps Pop
-
Goldman Sachs Upgrades Abbott Labs (ABT) to Buy
-
Jefferies Lifts PT on Pharmaceuticals Stocks (ABBV) (NVS) (SNY) (PFE)
-
Market Wrap: FOMC May End QE Early; Transocean Settles Up; Bausch & Lomb Draws Attention
-
Stocks Crossing 50-Day SMA 12/21: (AMD) (ABT) (P) Above; (NPSP) (BTU) (GBX) Below
-
Dell (DELL) No Longer a Mega-Cap Says S&P
-
Abbvie (ABBV) to Join S&P 500, Will Replace Fed. Investors (FII)
-
Leggett & Platt (LEG), Dividends Aristocrats and the Fiscal Cliff
-
Market Wrap: Sprint's Big M&A Day; Citi Runs Higher on Q3 Beat; New COO at Yahoo!; America's 'Nobel' Economists
-
Barclays Maintains an 'Equalweight' on Abbott Labs (ABT); Business Review & Form 10 Filing
-
Market Wrap: Morgan Stanley and Accounting Wizardry; Abbott Divorcing Itself; Citi, SEC Agree to Settle
-
S&P places Abbott Labs (ABT) on CreditWatch Negative
-
Q3 Preview: Johnson & Johnson (JNJ) Kicks Off Pharma Earnings; May Face Headwinds from FX, Generics
-
Abbott (ABT) Could See More Downside With Billion Dollar Cholesterol Franchise in Peril
-
Clough Capital Buys More Citigroup (C), Opens Petrohawk Energy (HK) Position and Lowers Cisco (CSCO)
-
George Soros' Hedge Fund Slashes Stake In Gold ETF (GLD), Raises Stake in Citi (C) and AT&T (T)
-
Oppenheimer Recommends Large Cap Stocks for 2011; Sees Solid Outperformance Versus Small Cap (WMT, JNJ, KO, more)
-
Daily State of the Markets 01/18: Has 'That Something' Arrived?
-
Abbott (ABT) Declares $0.44/Share Dividend, 3.8% Yield
-
S&P Stocks With High Levels of European Exposure (PM, GILD, MCD...)
-
Unusual Mid-Day Movers 12/15: LIMS, XRM, ARRY, IAX, DPTR Higher; TTHI, ESYS, GY, AIB Lower
-
Notable Analyst Rating Changes: ARO, CSX, PFWD, SIRI Upgraded; BRCD, BNI Downgraded
-
Top 10 News Items 9/28-10/02: Jobs Number Comes in Worse-Than-Expected; Ken Lewis to Retire from BofA at Year-End; Xerox Bids for ACS
-
M&A Deals Boost Stocks
-
James Simons' Renaissance Tech Hedge Fund Discloses Latest Moves; Ups Stakes In MCD, GOOG, AAPL, GS, more...
-
David Moenning's Daily State of the Markets: 4/24
-
S&P Announces Changes to US Index: SVR for EYE